DK3445763T3 - Hidtil ukendte krystallinske salteformer af 3-(1,2,4-triazolo[4,3-a]pyridin-3-ylethynyl)-4-methyl-n-(4-((4-methylpiperazin-1-yl)methyl)-3-trifluormethylphenyl)benzamid til medicinsk anvendelse - Google Patents
Hidtil ukendte krystallinske salteformer af 3-(1,2,4-triazolo[4,3-a]pyridin-3-ylethynyl)-4-methyl-n-(4-((4-methylpiperazin-1-yl)methyl)-3-trifluormethylphenyl)benzamid til medicinsk anvendelse Download PDFInfo
- Publication number
- DK3445763T3 DK3445763T3 DK17786237.2T DK17786237T DK3445763T3 DK 3445763 T3 DK3445763 T3 DK 3445763T3 DK 17786237 T DK17786237 T DK 17786237T DK 3445763 T3 DK3445763 T3 DK 3445763T3
- Authority
- DK
- Denmark
- Prior art keywords
- methyl
- salte
- ylethynyl
- crystallin
- methylpiperazin
- Prior art date
Links
- -1 1,2,4-TRIAZOLO [4,3-A] PYRIDIN-3-YLETHYNYL Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2016114904A RU2652992C2 (ru) | 2016-04-18 | 2016-04-18 | Новая кристаллическая солевая форма 3-(1,2,4-триазоло[4,3-а]пиридин-3-илэтинил)-4-метил-n-(4-((4-метилпиперазин-1-ил)метил)-3-трифторметилфенил)бензамида для медицинского применения |
| PCT/RU2017/050025 WO2017184032A1 (en) | 2016-04-18 | 2017-04-18 | Novel crystalline salt forms of 3-(1,2,4-triazolo[4,3-a]pyridine-3-ylethynyl)-4-methyl-n-(4-((4-methylpiperazin-1-yl)methyl)-3-trifluoromethylphenyl)benzamide for medical application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3445763T3 true DK3445763T3 (da) | 2022-01-31 |
Family
ID=60116178
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17786237.2T DK3445763T3 (da) | 2016-04-18 | 2017-04-18 | Hidtil ukendte krystallinske salteformer af 3-(1,2,4-triazolo[4,3-a]pyridin-3-ylethynyl)-4-methyl-n-(4-((4-methylpiperazin-1-yl)methyl)-3-trifluormethylphenyl)benzamid til medicinsk anvendelse |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US11225474B2 (da) |
| EP (1) | EP3445763B1 (da) |
| JP (1) | JP6463874B2 (da) |
| KR (1) | KR101929725B1 (da) |
| CN (1) | CN108473492B (da) |
| AU (1) | AU2017254345A1 (da) |
| BR (1) | BR112018071498A2 (da) |
| CA (1) | CA3021306C (da) |
| DK (1) | DK3445763T3 (da) |
| EA (1) | EA032865B1 (da) |
| ES (1) | ES2906048T3 (da) |
| HK (1) | HK1254731A1 (da) |
| IL (1) | IL262368A (da) |
| PL (1) | PL3445763T3 (da) |
| RU (1) | RU2652992C2 (da) |
| UA (1) | UA124627C2 (da) |
| WO (1) | WO2017184032A1 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2652992C2 (ru) | 2016-04-18 | 2018-05-04 | Общество С Ограниченной Ответственностью "Фьюжн Фарма" | Новая кристаллическая солевая форма 3-(1,2,4-триазоло[4,3-а]пиридин-3-илэтинил)-4-метил-n-(4-((4-метилпиперазин-1-ил)метил)-3-трифторметилфенил)бензамида для медицинского применения |
| RU2664420C1 (ru) * | 2017-10-31 | 2018-08-17 | Общество С Ограниченной Ответственностью "Фьюжн Фарма" | ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ДОЗИРОВКА И СПОСОБ ЛЕЧЕНИЯ Ph+ ЛЕЙКЕМИЙ |
| CN112505131B (zh) * | 2020-11-11 | 2023-01-13 | 山东省计量科学研究院 | 一甲基砷溶液标准物质的定值及其量值溯源方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101885722B (zh) * | 2010-07-01 | 2013-07-24 | 中国科学院广州生物医药与健康研究院 | 杂环炔苯类化合物及其药用组合物和应用 |
| RU2477772C2 (ru) | 2011-05-20 | 2013-03-20 | Государственное образовательное учреждение высшего профессионального образования "Саратовский государственный технический университет" | Устройство для бестраншейной прокладки трубопроводов способом прокола |
| RU2477723C2 (ru) | 2011-06-16 | 2013-03-20 | Общество С Ограниченной Ответственностью "Фьюжн Фарма" | Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе |
| WO2013170770A1 (zh) * | 2012-05-16 | 2013-11-21 | 上海医药集团股份有限公司 | 具有抗肿瘤活性的乙炔衍生物 |
| CN103848829B (zh) * | 2012-11-28 | 2017-04-12 | 南京圣和药业股份有限公司 | 杂芳基炔烃化合物及其应用 |
| GB2522226A (en) * | 2014-01-17 | 2015-07-22 | Agency Science Tech & Res | Heteroaryl alkyne derivatives and uses thereof |
| CN104250253B (zh) * | 2014-09-12 | 2017-04-05 | 辽宁大学 | 取代四氢化萘酰胺类化合物及其药学上可接受的盐及制备方法和应用 |
| RU2652992C2 (ru) | 2016-04-18 | 2018-05-04 | Общество С Ограниченной Ответственностью "Фьюжн Фарма" | Новая кристаллическая солевая форма 3-(1,2,4-триазоло[4,3-а]пиридин-3-илэтинил)-4-метил-n-(4-((4-метилпиперазин-1-ил)метил)-3-трифторметилфенил)бензамида для медицинского применения |
-
2016
- 2016-04-18 RU RU2016114904A patent/RU2652992C2/ru active
- 2016-06-01 EA EA201600487A patent/EA032865B1/ru unknown
-
2017
- 2017-04-18 JP JP2018522977A patent/JP6463874B2/ja active Active
- 2017-04-18 PL PL17786237T patent/PL3445763T3/pl unknown
- 2017-04-18 CA CA3021306A patent/CA3021306C/en active Active
- 2017-04-18 EP EP17786237.2A patent/EP3445763B1/en active Active
- 2017-04-18 BR BR112018071498-4A patent/BR112018071498A2/pt active Search and Examination
- 2017-04-18 US US16/094,790 patent/US11225474B2/en active Active
- 2017-04-18 KR KR1020187008765A patent/KR101929725B1/ko active IP Right Grant
- 2017-04-18 DK DK17786237.2T patent/DK3445763T3/da active
- 2017-04-18 UA UAA201811310A patent/UA124627C2/uk unknown
- 2017-04-18 ES ES17786237T patent/ES2906048T3/es active Active
- 2017-04-18 CN CN201780003746.XA patent/CN108473492B/zh active Active
- 2017-04-18 WO PCT/RU2017/050025 patent/WO2017184032A1/en active Application Filing
- 2017-04-18 AU AU2017254345A patent/AU2017254345A1/en not_active Abandoned
-
2018
- 2018-10-14 IL IL262368A patent/IL262368A/en unknown
- 2018-10-26 HK HK18113742.4A patent/HK1254731A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2017254345A1 (en) | 2018-11-22 |
| CN108473492A (zh) | 2018-08-31 |
| UA124627C2 (uk) | 2021-10-20 |
| CA3021306A1 (en) | 2017-10-26 |
| EP3445763A1 (en) | 2019-02-27 |
| PL3445763T3 (pl) | 2022-02-28 |
| IL262368A (en) | 2018-11-29 |
| WO2017184032A1 (en) | 2017-10-26 |
| US11225474B2 (en) | 2022-01-18 |
| CN108473492B (zh) | 2020-01-07 |
| US20200325131A1 (en) | 2020-10-15 |
| RU2652992C2 (ru) | 2018-05-04 |
| HK1254731A1 (zh) | 2019-07-26 |
| BR112018071498A2 (pt) | 2019-02-19 |
| EP3445763B1 (en) | 2021-11-10 |
| JP6463874B2 (ja) | 2019-02-06 |
| EA032865B1 (ru) | 2019-07-31 |
| EA201600487A1 (ru) | 2017-10-31 |
| KR20180037289A (ko) | 2018-04-11 |
| KR101929725B1 (ko) | 2018-12-14 |
| RU2016114904A (ru) | 2017-10-23 |
| JP2018530598A (ja) | 2018-10-18 |
| CA3021306C (en) | 2023-05-16 |
| EP3445763A4 (en) | 2019-12-04 |
| ES2906048T3 (es) | 2022-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1121071T1 (el) | Παραγωγα ναφθυριδινης ως ανταγωνιστες ιντεγκρινης αλφα v βητα 6 για τη θεραπεια π.χ. ινωτικων νοσων | |
| DK3800189T3 (da) | Fremstilling af (s)-n-(5-((r)-2-(2,5-difluorphenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidin-1-carboxamid | |
| MA45130A (fr) | Polymorphes de n-[(3-fluoro-4-méthoxypyridin-2-yl)méthyl]-3-(méthoxyméthyl)-1-({4-[2-oxopyridin-1-yl)méthyl]phényl}méthyl)pyrazole-4-carboxamide utilisés comme inhibiteurs de la kallicréine | |
| DK3319215T3 (da) | Høreinstrument, der omfatter switched capacitor dc-dc strømforsyning | |
| BR112016018450A2 (pt) | formas sólidas cristalinas de n-{4-[(6,7-dimetoxiquinolin-4-il)oxi]fenil}-n'-(4-fluorofenil)ciclopropano-1,1-dicarboxamida, processos de preparo e métodos de uso | |
| MA52623A (fr) | Dérivés de dihydropyrazolo pyrazine carboxamide substitués | |
| CY1121988T1 (el) | Θεραπευτικη αγωγη της πολλαπλης σκληρυνσης | |
| DK3445763T3 (da) | Hidtil ukendte krystallinske salteformer af 3-(1,2,4-triazolo[4,3-a]pyridin-3-ylethynyl)-4-methyl-n-(4-((4-methylpiperazin-1-yl)methyl)-3-trifluormethylphenyl)benzamid til medicinsk anvendelse | |
| GB201609519D0 (en) | Polymorphs of n-[(2,6-difluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyr idin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide | |
| IL254132B (en) | A solid preparation of N-(4-(1(2,6-difluorobenzyl)-5-))dimethylamino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxy-1,2,3 4-tetrahydrothiano[2,3-d]pyrimidine-6-yl)phenyl)-n-methoxyurea or its salt | |
| DK3526207T3 (da) | Heterocykliske forbindelser med aktivitet som modulatorer af muscarine m1- og/eller m4-receptorer i behandling af cns-sygdomme og smerter | |
| DK3296299T3 (da) | Krystalform af 3-ethyl-4-{3-isopropyl-4-(4-(1-methyl-1h-pyrazol-4-yl)-1h- imidazol-1-yl)-1h-pyrazolo[3,4-b]pyridin-1-yl}benzamid | |
| DK3749308T3 (da) | Behandling af patienter med klassisk fabrys sygdom med migalastat | |
| PL3827004T3 (pl) | Pochodne 4-(1,3,4-oksadiazol-2-ilo)pirydyn-2(1h)-onu jako inhibitory deacetylazy histonowej 6 (hdac6) do leczenia np. zakażeń | |
| DK3578562T3 (da) | L-valinatamidbenzoxaborolderivater til behandling af parasitiske sygdomme | |
| BR112018002140A2 (pt) | USO DE MARCADORES MOLECULARES IL-3, IL-33 e IL-12p40 PARA CARACTERIZAR ASGRAVIDADES DAS INFECÇÕES RESPIRATÓRIAS POR VÍRUS RESPIRATÓRIO SINCITIAL E METAPNEUMOVÍRUS HUMANO | |
| DK3624795T3 (da) | Kondenserede, heteroaromatiske anilinforbindelser til behandling af hudforstyrrelser | |
| DK3585327T3 (da) | System til behandling af søvnforstyrret åndedræt | |
| BR112018012095A2 (pt) | formas sólidas de compostos substituidos de 5,6-di-hidro-6-fenilbenzo[f]isoquinolin-2-amina | |
| DK3416654T3 (da) | Medicinsk anvendelse af 5'-adenosindiphosphatribose (adpr) | |
| DK3853219T3 (da) | Herbicidt virksomme substituerede phenylpyrimidinhydrazider | |
| DK3834788T3 (da) | Engangsble til voksne | |
| IT201800007580A1 (it) | Composti 1,3,8-triazaspiro e loro uso come medicamenti | |
| DK3164385T3 (da) | Ny polymorf form af n-[2-(6-fluor-lh-indol-3-yl)ethyl]-3-(2,2,3,3-tetrafluorpropoxy)benzylaminhydrochlorid for behandlingen af alzheimers | |
| UA37676S (uk) | Екогриль дерев'яний одноразовий |